Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-064598
Filing Date
2025-03-27
Accepted
2025-03-27 06:08:34
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d906590ddefa14a.htm DEFA14A 24767
2 GRAPHIC g906590g00a02.jpg GRAPHIC 62218
3 GRAPHIC g906590g00a06.jpg GRAPHIC 24290
4 GRAPHIC g906590g55m08.jpg GRAPHIC 4903
5 GRAPHIC g906590gra03d.jpg GRAPHIC 1361
6 GRAPHIC g906590gra03e.jpg GRAPHIC 1244
7 GRAPHIC g906590gra03f.jpg GRAPHIC 1290
8 GRAPHIC g906590gra03g.jpg GRAPHIC 2721
9 GRAPHIC g906590im01b.jpg GRAPHIC 2758
  Complete submission text file 0001193125-25-064598.txt   165896
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39248 | Film No.: 25775040
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)